• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Infections

Posted inClinical Trials, Infections

Doxycycline Protects Against Gonorrhea, Chlamydia, and Syphilis Infections

by Mark Gubar August 4, 2022September 8, 2022

It is necessary to take the antibiotic doxycycline after sex without a condom.

Posted inClinical Trials, Infections, New Drugs, Regulatory

Hepcludex: Effective Treatment for Chronic Hepatitis D

by Julia Mardi July 18, 2022September 8, 2022

Bulevirtide is the only approved antiviral drug against hepatitis delta.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19

by Mark Gubar July 14, 2022April 11, 2024

Covovax/Nuvaxovid by Novavax is a protein subunit vaccine from virus-like particles.

olorofim
Posted inClinical Trials, Infections, Rare/Orphan Diseases

Olorofim: New Antifungal Drug

by Tanya von Reuss June 9, 2022September 8, 2022

Olorophim by F2G and Shionogi & Co. is focused on invasive aspergillosis treatment.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

by Mark Gubar June 8, 2022September 8, 2022

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine

by Nik Resovski June 5, 2022April 11, 2024

Innovative Medicago’s vaccine is made by molecular pharming technology.

Posted inInfections, New Drugs, Oncology, Regulatory

Talicia: Highly Effective Eradication Regimen for Helicobacter pylori

by Tanya von Reuss June 5, 2022September 8, 2022

Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.

Posts pagination

Newer posts 1 2 3 4 5 … 9 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×